864767-29-3

Basic information

• Product Name: [(cyclopentadienyl)(titanium)(chloride)(C₅H₄C(CH₃)2CH₂C(NH(Bn))O)] chloride
• Synonyms: [(cyclopentadienyl)(titanium)(chloride)(C₅H₄C(CH₃)2CH₂C(NH(Bn))O)] chloride
• CAS NO: 864767-29-3
• Molecular Weight: 438.233
• Mol File: 864767-29-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [(cyclopentadienyl)(titanium)(chloride)(C₅H₄C(CH₃)2CH₂C(NH(Bn))O)] chloride(CAS DataBase Reference)
• NIST Chemistry Reference: [(cyclopentadienyl)(titanium)(chloride)(C₅H₄C(CH₃)2CH₂C(NH(Bn))O)] chloride(864767-29-3)
• EPA Substance Registry System: [(cyclopentadienyl)(titanium)(chloride)(C₅H₄C(CH₃)2CH₂C(NH(Bn))O)] chloride(864767-29-3)

Safety Data

• Hazardous Substances Data: 864767-29-3(Hazardous Substances Data)

Upstream product

• 864767-00-0 Cp(CpCMe₂CH₂COCl)titanium(IV)dichloride 
• 100-46-9 benzylamine 

Relevant articles and documents

In vitro and in vivo trackable titanocene-based complexes using optical imaging or SPECT

A novel Ti/111In-heterometallic radiotheranostic along with non-radioactive Ti/In, Ti/Lu, and Ti/Y analogues has been reported, thanks to the design of a challenging synthesis of the first titanocene-DOTA ligand. The corresponding titanocene-BODIPY complex was developed for in vitro tracking by optical imaging. The different complexes were characterized and their antiproliferative properties were evaluated on three cancer cell lines (A2780, B16F1, and PC3). As a proof of concept, initial studies in healthy mice were performed with a Ti/111In derivative to obtain information about its uptake, its biodistribution, and its excretion. Confocal microscopy experiments were performed with fluorescent complexes to track it in vitro.